Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination. - Geers D; Aguilar-Bretones M; Zaeck LM; Gill PA; Gonzalez-Lopez C; Handrejk K; Tan NH; den Hartog Y; Gommers L; Bogers S; Mykytyn AZ; Sablerolles RSG; et al. (The Journal of infection, 2026)